Inovio Results from Phase 1/2 Study of INO-3107 for Recurrent Respiratory Papillomatosis

 Data shows that INO-3107 induced new populations of T cells in the blood that traveled to airway tissue and were associated with clinical benefit as measured by reduced need for surgeries

https://www.prnewswire.com/news-releases/clinical-and-immunological-results-from-phase-12-study-of-ino-3107-as-a-treatment-for-recurrent-respiratory-papillomatosis-published-in-nature-communications-302374685.html